Edition:
United Kingdom

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

7.79USD
17 Aug 2018
Change (% chg)

$-0.20 (-2.50%)
Prev Close
$7.99
Open
$7.89
Day's High
$8.15
Day's Low
$7.65
Volume
17,569
Avg. Vol
90,508
52-wk High
$13.54
52-wk Low
$2.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.21 -0.407
Mar '18 0.00 -0.301
FY 2017 Dec '17 0.00 -0.254
Sep '17 0.00 -0.390
FY 2016 Dec '16 0.00 -0.187
Sep '16 0.00 -0.289
Jun '16 0.00 0.916
Mar '16 0.00 -0.807
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.64 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.98 5.75
Price to Book (MRQ) -- 15.51 5.00
Price to Tangible Book (MRQ) -- 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -100.00 80.50 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -2,764.52 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago 59.54 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 5.31 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -32.94 -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -603.21 10.65
Operating Margin (TTM) -- -759.76 4.32
Operating Margin - 5 Yr. Avg. -- -625.13 6.06
Pre-Tax Margin (TTM) -- -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -628.46 6.49
Net Profit Margin (TTM) -- -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -- -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,989 860,375,103
Net Income/Employee (TTM) -- 3,144,143 101,207,184
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -596.34 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.50 12.40
Return on Investment (TTM) -911.19 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.55 16.13
Return on Equity (TTM) -911.19 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 65.78 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for TapImmune Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.